2004
DOI: 10.1016/j.jaci.2004.03.057
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of allergic airway disease using mycobacterial lipoglycans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
65
0

Year Published

2009
2009
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(69 citation statements)
references
References 35 publications
4
65
0
Order By: Relevance
“…Furthermore, PIMs have been reported to suppress allergic airway disease, which is associated with increased production of IL-10 (2, 63). However, PIM 1 and PIM 2 were used in the latter two studies (2,63) and IL-10 induction in this case likely involves a different pathway (22). In our experiments, in which LPS-primed MoDCs were cocultured with wild-type M. bovis BCG or the ⌬pimE and ⌬pimE ⌬capA mutant strains, no decrease in IL-10 secretion by MoDCs incubated with the mutant strains compared to wild-type M. bovis BCG was found (Fig.…”
Section: Discussionmentioning
confidence: 63%
“…Furthermore, PIMs have been reported to suppress allergic airway disease, which is associated with increased production of IL-10 (2, 63). However, PIM 1 and PIM 2 were used in the latter two studies (2,63) and IL-10 induction in this case likely involves a different pathway (22). In our experiments, in which LPS-primed MoDCs were cocultured with wild-type M. bovis BCG or the ⌬pimE and ⌬pimE ⌬capA mutant strains, no decrease in IL-10 secretion by MoDCs incubated with the mutant strains compared to wild-type M. bovis BCG was found (Fig.…”
Section: Discussionmentioning
confidence: 63%
“…Mycobacterial cell wall components (lipoglycans lipoarabinomannan, and phosphatidylinositol mannan) also have been shown to suppress AAD; however, their effects on AHR have not been determined (38). Furthermore, mycobacterial phosphatidylinositol mannoside has been reported to bind CD1d and activate human and mouse NKT cells, which may be a problem for the therapeutic use of mycobacterial components (39).…”
Section: Discussionmentioning
confidence: 99%
“…Although numerous reported epidemiological and experimental studies have demonstrated the inhibitory role of live or killed microbes or microbial components on allergic responses [18][19][20][21][22][23][24][25], the basis for this inhibition remains unclear. In particular, little experimental study has been performed on the effect and mechanism of neonatal microbial exposure on airway allergic inflammation.…”
Section: Discussionmentioning
confidence: 99%